All Eyes on mRNA - Addressing Key Insights into the Next Blockbuster

4:15 PM - 5:15 PM (PDT), Tuesday, June 14, 2022 ・ Upper Level, Session Room 5A

Scientific breakthroughs during the pandemic are driving a lot of optimism around mRNA technology, leading to billion dollar collaboration deals for biotechs with global pharma companies.  With ongoing development efforts seeing promise against old enemies such as HIV and infinite possibilities for cancers, autoimmune diseases, genetic diseases and beyond, how should the industry apply this early victory into successful mRNA-based therapeutics and vaccines in these new disease settings?  Come join this panel of notable industry experts discuss current market trends, share insights to what's being considered for mRNA technology and give guidance on what to look for in a partner.

Sponsored By
Moderator
Speakers
photo
CTO
HDT Bio
photo
Head of Manufacturing
Samsung Biologics
photo
Chief Operating Officer
GreenLight Biosciences
photo
CEO
Pencil Biosciences